A Clayman Thyroid Center report aims to clarify FDA safety warnings, finding no evidence that GLP-1 drugs like Ozempic cause common thyroid cancers. Current human data do not show a link between GLP-1 ...

With the rapid rise in use of GLP-1 receptor agonist medications such as Ozempic®, Wegovy®, and Mounjaro® for diabetes and weight loss, public concern has grown over a possible link to thyroid cancer.

In 2023, about 44,000 Americans were diagnosed with thyroid cancer. Although thyroid cancer is not as common as breast, prostate, lung, or colon cancer, it can still be serious. So, let’s talk about ...

A new review finds no convincing evidence that drugs like Ozempic raise people's risk of common thyroid cancers.

MONDAY, Nov. 17, 2025 (HealthDay News) — Thyroid cancer is often a highly treatable disease. Most cases are detected in early stages and have excellent outcomes. There are several different types of ...

A new white paper issued by the Clayman Thyroid Center in Tampa, Florida, concludes that popular GLP-1 receptor agonists ...

The father of two said he has already undergone surgery to have the cancer removed, but will continue to monitor his diagnosis ...

Papillary thyroid cancer staging depends on age, with stage 2 involving distant spread in younger patients and larger tumors or regional spread in older patients. Diagnosis involves physical exams, ...

Please provide your email address to receive an email when new articles are posted on . Being diagnosed with thyroid cancer and hypoparathyroidism may raise risk for several comorbidities. Targeted ...

Please provide your email address to receive an email when new articles are posted on . Patients with primary thyroid cancer who received radioactive iodine therapy had elevated risk for melanoma/skin ...

A person can have thyroid cancer for months or years without experiencing any symptoms. Symptoms may not develop until the cancer advances. The thyroid is a gland at the base of the throat that sends ...